1. Home
  2. BHIL vs GOVX Comparison

BHIL vs GOVX Comparison

Compare BHIL & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHIL
  • GOVX
  • Stock Information
  • Founded
  • BHIL 2012
  • GOVX 2001
  • Country
  • BHIL United States
  • GOVX United States
  • Employees
  • BHIL N/A
  • GOVX N/A
  • Industry
  • BHIL Packaged Foods
  • GOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BHIL Consumer Staples
  • GOVX Health Care
  • Exchange
  • BHIL Nasdaq
  • GOVX Nasdaq
  • Market Cap
  • BHIL 27.1M
  • GOVX 23.8M
  • IPO Year
  • BHIL N/A
  • GOVX N/A
  • Fundamental
  • Price
  • BHIL $2.69
  • GOVX $2.29
  • Analyst Decision
  • BHIL
  • GOVX Strong Buy
  • Analyst Count
  • BHIL 0
  • GOVX 5
  • Target Price
  • BHIL N/A
  • GOVX $14.20
  • AVG Volume (30 Days)
  • BHIL 35.4K
  • GOVX 721.3K
  • Earning Date
  • BHIL 11-12-2024
  • GOVX 11-12-2024
  • Dividend Yield
  • BHIL N/A
  • GOVX N/A
  • EPS Growth
  • BHIL N/A
  • GOVX N/A
  • EPS
  • BHIL N/A
  • GOVX N/A
  • Revenue
  • BHIL $466,725,000.00
  • GOVX $3,090,161.00
  • Revenue This Year
  • BHIL N/A
  • GOVX N/A
  • Revenue Next Year
  • BHIL N/A
  • GOVX $150.51
  • P/E Ratio
  • BHIL N/A
  • GOVX N/A
  • Revenue Growth
  • BHIL 139.60
  • GOVX N/A
  • 52 Week Low
  • BHIL $1.86
  • GOVX $1.09
  • 52 Week High
  • BHIL $11.03
  • GOVX $11.18
  • Technical
  • Relative Strength Index (RSI)
  • BHIL 35.35
  • GOVX 45.52
  • Support Level
  • BHIL $1.86
  • GOVX $2.17
  • Resistance Level
  • BHIL $3.17
  • GOVX $2.47
  • Average True Range (ATR)
  • BHIL 0.38
  • GOVX 0.18
  • MACD
  • BHIL 0.10
  • GOVX -0.03
  • Stochastic Oscillator
  • BHIL 48.55
  • GOVX 23.53

About BHIL Benson Hill Inc.

Benson Hill Inc is an ag-tech company specializing in soy protein innovation. The company has one business segment Ingredient. The company focuses on seed innovation through proprietary germplasm and the CropOS platform. This platform integrates protein, genomic, and strategic data for predictive breeding using AI and ML. They operate a Crop Accelerator for rapid prototyping. Benson Hill is developing a seed portfolio for protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company's revenue can be disaggregated into product categories: Proprietary and Non-Proprietary. Proprietary revenue is defined as any sale of a proprietary bean. Non-Proprietary revenue is all other revenue from non-Proprietary sources.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.

Share on Social Networks: